TrialMedical oncology (Northwood, London, England)2014

Survivin as prognostic and predictive factor in patients treated with gemcitabine, dexamethasone, and cisplatin for relapsed or refractory aggressive NHL.

Lamiss Mohamed Abd el AzizPubMed ↗Publisher ↗

No numbers read from the abstract.